Malik K - Search Results

1

PRMT1 promotes neuroblastoma cell survival through ATF5.

Hua ZY, Hansen JN, He M, Dai SK, Choi Y, Fulton MD, Lloyd SM, Szemes M, Sen J, Ding HF, Angelastro JM, Fei X, Li HP, Wu CR, Yang SY, Malik K, Bao X, George Zheng Y, Liu CM, Schor NF, Li ZJ, Li XG. Hua ZY, et al. Among authors: malik k. Oncogenesis. 2020 May 15;9(5):50. doi: 10.1038/s41389-020-0237-9. Oncogenesis. 2020. PMID: 32415090 Free PMC article.

2

Wnt Signaling Is a Major Determinant of Neuroblastoma Cell Lineages.

Szemes M, Greenhough A, Malik K. Szemes M, et al. Among authors: malik k. Front Mol Neurosci. 2019 Apr 16;12:90. doi: 10.3389/fnmol.2019.00090. eCollection 2019. Front Mol Neurosci. 2019. PMID: 31040767 Free PMC article.

3

MYCN is recruited to the RASSF1A promoter but is not critical for DNA hypermethylation in neuroblastoma.

Charlet J, Szemes M, Malik KT, Brown KW. Charlet J, et al. Mol Carcinog. 2014 May;53(5):413-20. doi: 10.1002/mc.21994. Epub 2012 Dec 31. Mol Carcinog. 2014. PMID: 23280764

4

A Wnt-BMP4 Signaling Axis Induces MSX and NOTCH Proteins and Promotes Growth Suppression and Differentiation in Neuroblastoma.

Szemes M, Melegh Z, Bellamy J, Greenhough A, Kollareddy M, Catchpoole D, Malik K. Szemes M, et al. Among authors: malik k. Cells. 2020 Mar 23;9(3):783. doi: 10.3390/cells9030783. Cells. 2020. PMID: 32210188 Free PMC article.

5

Increased Efficacy of Histone Methyltransferase G9a Inhibitors Against MYCN-Amplified Neuroblastoma.

Bellamy J, Szemes M, Melegh Z, Dallosso A, Kollareddy M, Catchpoole D, Malik K. Bellamy J, et al. Among authors: malik k. Front Oncol. 2020 May 27;10:818. doi: 10.3389/fonc.2020.00818. eCollection 2020. Front Oncol. 2020. PMID: 32537432 Free PMC article.

6

LGR5 regulates pro-survival MEK/ERK and proliferative Wnt/β-catenin signalling in neuroblastoma.

Vieira GC, Chockalingam S, Melegh Z, Greenhough A, Malik S, Szemes M, Park JH, Kaidi A, Zhou L, Catchpoole D, Morgan R, Bates DO, Gabb PD, Malik K. Vieira GC, et al. Among authors: malik k, malik s. Oncotarget. 2015 Nov 24;6(37):40053-67. doi: 10.18632/oncotarget.5548. Oncotarget. 2015. PMID: 26517508 Free PMC article.

7

Transcriptomic Analyses of MYCN-Regulated Genes in Anaplastic Wilms' Tumour Cell Lines Reveals Oncogenic Pathways and Potential Therapeutic Vulnerabilities.

Szemes M, Melegh Z, Bellamy J, Park JH, Chen B, Greenhough A, Catchpoole D, Malik K. Szemes M, et al. Among authors: malik k. Cancers (Basel). 2021 Feb 6;13(4):656. doi: 10.3390/cancers13040656. Cancers (Basel). 2021. PMID: 33562123 Free PMC article.

8

Epigenetic deregulation of GATA3 in neuroblastoma is associated with increased GATA3 protein expression and with poor outcomes.

Almutairi B, Charlet J, Dallosso AR, Szemes M, Etchevers HC, Malik KTA, Brown KW. Almutairi B, et al. Sci Rep. 2019 Dec 12;9(1):18934. doi: 10.1038/s41598-019-55382-6. Sci Rep. 2019. PMID: 31831790 Free PMC article.

9

Protein arginine methyltransferase 5 is a key regulator of the MYCN oncoprotein in neuroblastoma cells.

Park JH, Szemes M, Vieira GC, Melegh Z, Malik S, Heesom KJ, Von Wallwitz-Freitas L, Greenhough A, Brown KW, Zheng YG, Catchpoole D, Deery MJ, Malik K. Park JH, et al. Among authors: malik k, malik s. Mol Oncol. 2015 Mar;9(3):617-27. doi: 10.1016/j.molonc.2014.10.015. Epub 2014 Nov 15. Mol Oncol. 2015. PMID: 25475372 Free PMC article.

10

Wnt Signalling Drives Context-Dependent Differentiation or Proliferation in Neuroblastoma.

Szemes M, Greenhough A, Melegh Z, Malik S, Yuksel A, Catchpoole D, Gallacher K, Kollareddy M, Park JH, Malik K. Szemes M, et al. Among authors: malik k, malik s. Neoplasia. 2018 Apr;20(4):335-350. doi: 10.1016/j.neo.2018.01.009. Epub 2018 Mar 3. Neoplasia. 2018. PMID: 29505958 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

995 results

Search Page